loadpatents
name:-0.038341999053955
name:-0.02316689491272
name:-0.0092711448669434
PETROCCHI; Alessia Patent Filings

PETROCCHI; Alessia

Patent Applications and Registrations

Patent applications and USPTO patent grants for PETROCCHI; Alessia.The latest application filed is for "shp2 inhibitors".

Company Profile
8.24.40
  • PETROCCHI; Alessia - Pomezia RM
  • Petrocchi; Alessia - Houston TX
  • Petrocchi; Alessia - Boston MA
  • Petrocchi; Alessia - Rome IT
  • Petrocchi; Alessia - Pomezia IT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Shp2 Inhibitors
App 20220289753 - CIAMMAICHELLA; Alina ;   et al.
2022-09-15
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
Grant 11,173,145 - Lewis , et al. November 16, 2
2021-11-16
Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
Grant 11,046,649 - Lewis , et al. June 29, 2
2021-06-29
Heterocyclic modulators of HIF activity for treatment of disease
Grant 11,001,594 - Jones , et al. May 11, 2
2021-05-11
Gls1 Inhibitors For Treating Disease
App 20210122744 - LEWIS; Richard Thomas ;   et al.
2021-04-29
GLS1 inhibitors for treating disease
Grant 10,738,043 - Lewis , et al. A
2020-08-11
Compounds Useful As Inhibitors Of Indoleamine 2,3-dioxygenase And/or Tryptophan Dioxygenase
App 20200024236 - LEWIS; Richard T. ;   et al.
2020-01-23
Compounds Useful As Inhibitors Of Indoleamine 2,3-dioxygenase And/or Tryptophan Dioxygenase
App 20190365718 - LEWIS; Richard T. ;   et al.
2019-12-05
Heterocyclic Modulators Of Hif Activity For Treatment Of Disease
App 20190270753 - JONES; Philip ;   et al.
2019-09-05
Heterocyclic Inhibitors Of Kdm5 For The Treatment Of Disease
App 20190135793 - PETROCCHI; Alessia ;   et al.
2019-05-09
Heterocyclic modulators of HIF activity for treatment of disease
Grant 10,208,059 - Jones , et al. Feb
2019-02-19
Gls1 Inhibitors For Treating Disease
App 20190031651 - LEWIS; Richard Thomas ;   et al.
2019-01-31
GLS1 inhibitors for treating disease
Grant 10,125,128 - Lewis , et al. November 13, 2
2018-11-13
Thiazole-substituted aminoheteroaryls as Spleen Tyrosine Kinase inhibitors
Grant 9,670,196 - Miller , et al. June 6, 2
2017-06-06
Heterocyclic Modulators Of Hif Activity For Treatment Of Disease
App 20170121342 - Jones; Philip ;   et al.
2017-05-04
Gls1 Inhibitors For Treating Disease
App 20170001996 - Lewis; Richard Thomas ;   et al.
2017-01-05
Thiazole-substituted Aminoheteroaryls As Spleen Tyrosine Kinase Inhibitors
App 20160326156 - Miller; Thomas A. ;   et al.
2016-11-10
Imidazolyl analogs as syk inhibitors
Grant 9,487,504 - Lim , et al. November 8, 2
2016-11-08
Heterocyclic modulators of HIF activity for treatment of disease
Grant 9,481,692 - Jones , et al. November 1, 2
2016-11-01
Aminopyrimidines as Syk inhibitors
Grant 9,290,490 - Altman , et al. March 22, 2
2016-03-22
Bromodomain Inhibitors For Treating Disease
App 20160060260 - Palmer; Wylie ;   et al.
2016-03-03
HCV NS3 Protease Inhibitors
App 20150266897 - Liverton; Nigel J. ;   et al.
2015-09-24
Heterocyclic Modulators Of Hif Activity For Treatment Of Disease
App 20150252058 - Jones; Philip ;   et al.
2015-09-10
Heterocyclic modulators of HIF activity for treatment of disease
Grant 9,115,120 - Jones , et al. August 25, 2
2015-08-25
Imidazolyl Analogs As Syk Inhibitors
App 20150175575 - Lim; Jongwon ;   et al.
2015-06-25
Compounds that are ERK inhibitors
Grant 9,023,865 - Lim , et al. May 5, 2
2015-05-05
Heterocyclic modulators of HIF activity for treatment of disease
Grant 9,018,380 - Jones , et al. April 28, 2
2015-04-28
Novel Compounds That Are Erk Inhibitors
App 20140296203 - Lim; Jongwon ;   et al.
2014-10-02
Aminopyrimidines as SYK Inhibitors
App 20140243290 - Altman; Michael D. ;   et al.
2014-08-28
Aminopyrimidines As Syk Inhibitors
App 20140148474 - Altman; Michael D. ;   et al.
2014-05-29
Heterocyclic Modulators Of Hif Activity For Treatment Of Disease
App 20140073634 - Jones; Philip ;   et al.
2014-03-13
Heterocyclic Modulators Of Hif Activity For Treatment Of Disease
App 20140066424 - Jones; Philip ;   et al.
2014-03-06
Heterocyclic Modulators Of Hif Activity For Treatment Of Disease
App 20140057914 - Jones; Philip ;   et al.
2014-02-27
3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
Grant 8,354,545 - Stachel , et al. January 15, 2
2013-01-15
Aminopyrimidines As Syk Inhibitors
App 20120277192 - Altman; Michael D. ;   et al.
2012-11-01
Hiv Integrase Inhibitors
App 20110257162 - Summa; Vincenzo ;   et al.
2011-10-20
Aminopyrimidines As Syk Inhibitors
App 20110245205 - Altman; Michael D. ;   et al.
2011-10-06
N-substituted Hydroxypyrimidinone Carboxamide Inhibitors Of Hiv Integrase
App 20110034449 - Crescenzi; Benedetta ;   et al.
2011-02-10
3,4-substituted Pyrrolidine Beta-secretase Inhibitors For The Treatment Of Alzheimer's Disease
App 20100280009 - Stachel; Shawn J. ;   et al.
2010-11-04
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
Grant 7,820,660 - Crescenzi , et al. October 26, 2
2010-10-26
HCV NS3 Protease Inhibitors
App 20100099695 - Liverton; Nigel J. ;   et al.
2010-04-22
HIV Integrase Inhibitors
App 20090253681 - Summa; Vincenzo ;   et al.
2009-10-08
Tetracyclic Indole Derivatives as Antiviral Agents
App 20090136449 - Di Filippo; Marcello ;   et al.
2009-05-28
Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
Grant 7,459,452 - Di Francesco , et al. December 2, 2
2008-12-02
N-Substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
App 20080275004 - Crescenzi; Benedetta ;   et al.
2008-11-06
Amide Derivatives as Inhibitors of Histone Deacetylase
App 20080262035 - Chakravarty; Prasun K. ;   et al.
2008-10-23
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
Grant 7,435,734 - Crescenzi , et al. October 14, 2
2008-10-14
Amide Derivatives as Inhibitors of Histone Deacetylase
App 20080221157 - Chakravarty; Prasun K. ;   et al.
2008-09-11
Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
Grant 7,232,819 - Di Francesco , et al. June 19, 2
2007-06-19
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
App 20070123524 - Crescenzi; Benedetta ;   et al.
2007-05-31
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
Grant 7,217,713 - Crescenzi , et al. May 15, 2
2007-05-15
Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
App 20070083045 - Di Francesco; Maria E. ;   et al.
2007-04-12
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
Grant 7,169,780 - Crescenzi , et al. January 30, 2
2007-01-30
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
App 20060258860 - Crescenzi; Benedetta ;   et al.
2006-11-16
Peptides and their use as inhibitors of hepatitis C virus ns3 protease
Grant 7,119,073 - Colarusso , et al. October 10, 2
2006-10-10
Pyrimidinone viral polymerase inhibitors
App 20050130997 - Avolio, Salvatore ;   et al.
2005-06-16
Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
App 20050075356 - Di Francesco, Maria E. ;   et al.
2005-04-07
Peptides and their use as inhibitors of hepatitis c virus ns3 protease
App 20040142876 - Colarusso, Stefania ;   et al.
2004-07-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed